The DOI matches its Crossref record.
Human tumor necrosis factor potentiates human interleukin 1-mediated rat pancreatic beta-cell cytotoxicity.
Abstract
Previous studies have established that the cytokine interleukin 1 (IL-1) is selectively cytotoxic for isolated human and rat pancreatic beta-cells. This observation raises the possibility that insulin-dependent diabetes mellitus is in part due to immunologically mediated mechanisms involving IL-1. However, other cytokines are produced during immunologic responses. To study possible modulatory effects of other cytokines on IL-1-mediated beta-cell cytotoxicity, we added human recombinant IL-1 alpha and beta (rIL-1 alpha, rIL-1 beta), tumor necrosis factor (rTNF), lymphotoxin (rLT), and interferon-gamma (rIFN-gamma) separately or in combinations to the culture medium of isolated rat islets of Langerhans. A half-maximal inhibition of glucose-stimulated insulin release after 7 days of culture was obtained with 100 pg/ml of rIL-1 beta, whereas 1000 pg/ml of rIL-1 alpha were necessary to obtain an equivalent effect. While ineffective in causing inhibition of beta-cell function or morphologic damage to islets alone 2.5 to 25 ng/ml of rTNF, but not 40 ng/ml of rLT, or 25 ng/ml of rIFN-gamma markedly potentiated the inhibition of beta-cell secretory response and dissolution of islet integrity caused by rIL-1 alpha and beta. The potentiating effect of rTNF was more pronounced if the rTNF was added after 60 min of preincubation of the islets with rIL-1 beta, than if rIL-1 beta was added after 60 min of preincubation with rTNF. rTNF did not interfere with the activity of rIL-1 alpha or beta on lymphocytes. Combinations of rIFN-gamma and rTNF or rLT did not affect beta-cell function. In conclusion, rTNF strongly potentiates the functional inhibition of beta-cells and the morphologic disintegration of islets caused by rIL-1 in vitro. These data, seen in context with previous observations of rIL-1-mediated beta-cell cytotoxicity, suggest that macrophages present in the intra-islet mononuclear cell infiltrate in insulin-dependent diabetes mellitus may secrete monokines that could be important effector molecules in beta-cell destruction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Endres, S., Ghorbani, R., Kelley, V. E., Georgilis, K., Lonnemann, G., van der Meer, J. W. M., Cannon, J. G., Rogers, T. S., Klempner, M. S., Weber, P. C., et al. (1989) · New England Journal of Medicine · doi:10.1056/nejm198902023200501 · Cited by 1,910
Self-citationInterleukin-1 and Its Biologically Related Cytokines
Dinarello, C. A. (1989) · Advances in Immunology · doi:10.1016/s0065-2776(08)60642-2 · Cited by 1,151
Self-citationPOCIOT, F., MØLVIG, J., WOGENSEN, L., WORSAAE, H., & NERUP, J. (1992) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1992.tb01480.x · Cited by 921
Self-citationβ-Cell death during progression to diabetes
Mathis, D., Vence, L., & Benoist, C. (2001) · Nature · doi:10.1038/414792a · Cited by 884
IL-18: A TH1 -inducing, proinflammatory cytokine and new member of the IL-1 family
Dinarello, C. A. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70518-x · Cited by 819
Self-citationPociot, F., Briant, L., Jongeneel, C. V., Mölvig, J., Worsaae, H., Abbal, M., Thomsen, M., Nerup, J., & Cambon‐Thomsen, A. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230135 · Cited by 548
Self-citationThe role of interleukin-1 in the pathogenesis of IDDM
Mandrup-Poulsen, T. (1996) · Diabetologia · doi:10.1007/bf00400649 · Cited by 543
Self-citationInflammatory mediators and islet ?-cell failure: a link between type 1 and type 2 diabetes
Donath, M. Y., St�rling, J., Maedler, K., & Mandrup-Poulsen, T. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0450-y · Cited by 422
Self-citationAnticytokine Strategies in the Treatment of the Systemic Inflammatory Response Syndrome
Dinarello, C. A. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500140081040 · Cited by 405
Self-citationOverview of interleukin-18: more than an interferon-γ inducing factor
Dinarello, C. A., Novick, D., Puren, A. J., Fantuzzi, G., Shapiro, L., Mühl, H., Yoon, D.-Y., Reznikov, L. L., Kim, S.-H., & Rubinstein, M. (1998) · Journal of Leukocyte Biology · doi:10.1002/jlb.63.6.658 · Cited by 374
Self-citationClinical islet transplantation: advances and immunological challenges
Ricordi, C., & Strom, T. B. (2004) · Nature Reviews Immunology · doi:10.1038/nri1332 · Cited by 368
Southern, C., Schulster, D., & Green, I. C. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)80502-a · Cited by 362
Jacob, C. O., Aiso, S., Michie, S. A., McDevitt, H. O., & Acha-Orbea, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.968 · Cited by 349
Cytokine levels in the cerebrospinal fluid and serum of patients with multiple sclerosis
Maimone, D., Gregory, S., Arnason, B. G. W., & Reder, A. T. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90073-g · Cited by 333
Role of IL-1β in type 2 diabetes
Dinarello, C. A., Donath, M. Y., & Mandrup-Poulsen, T. (2010) · Current Opinion in Endocrinology, Diabetes & Obesity · doi:10.1097/med.0b013e32833bf6dc · Cited by 327
Self-citationHypothyroidism after Treatment with Interleukin-2 and Lymphokine-Activated Killer Cells
Atkins, M. B., Mier, J. W., Parkinson, D. R., Gould, J. A., Berkman, E. M., & Kaplan, M. M. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806163182401 · Cited by 318
Autoimmune Destruction of Pancreatic β Cells
Yoon, J.-W., & Jun, H.-S. (2005) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000178767.67857.63 · Cited by 308
Etanercept Treatment in Children With New-Onset Type 1 Diabetes
Mastrandrea, L., Yu, J., Behrens, T., Buchlis, J., Albini, C., Fourtner, S., & Quattrin, T. (2009) · Diabetes Care · doi:10.2337/dc09-0054 · Cited by 280
The Role of Macrophages in T Cell–mediated Autoimmune Diabetes in Nonobese Diabetic Mice
Jun, H.-S., Yoon, C.-S., Zbytnuik, L., van Rooijen, N., & Yoon, J.-W. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.347 · Cited by 279
Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus
Christensen, D. P., Dahllöf, M., Lundh, M., Rasmussen, D. N., Nielsen, M. D., Billestrup, N., Grunnet, L. G., & Mandrup-Poulsen, T. (2011) · Molecular Medicine · doi:10.2119/molmed.2011.00021 · Cited by 261
Self-citationUpregulation of insulin receptor substrate-2 in pancreatic β cells prevents diabetes
Hennige, A. M., Burks, D. J., Ozcan, U., Kulkarni, R. N., Ye, J., Park, S., Schubert, M., Fisher, T. L., Dow, M. A., Leshan, R., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18581 · Cited by 262
Mitrovic, B., Ignarro, L. J., Montestruque, S., Smoll, A., & Merrill, J. E. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90435-9 · Cited by 259
MØLVIG, J., BAEK, L., CHRISTENSEN, P., MANOGUE, K. R., VLASSARA, H., PLATZ, P., NIELSEN, L. S., SVEJGAARD, A., & NERUP, J. (1988) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.1988.tb02404.x · Cited by 259
Self-citationTreatment with an Interleukin 1 beta antibody improves glycemic control in diet-induced obesity
Osborn, O., Brownell, S. E., Sanchez-Alavez, M., Salomon, D., Gram, H., & Bartfai, T. (2008) · Cytokine · doi:10.1016/j.cyto.2008.07.004 · Cited by 160
“ated cytotoxicity in the pancreas [63].”
Dula, S. B., Jecmenica, M., Wu, R., Jahanshahi, P., Verrilli, G. M., Carter, J. D., Brayman, K. L., & Nunemaker, C. S. (2010) · Cell Calcium · doi:10.1016/j.ceca.2010.07.007 · Cited by 83
Metadata
- Authors
- Mandrup-Poulsen, T., Bendtzen, K., Dinarello, C. A., & Nerup, J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1987-12
- Volume
- 139
- Issue
- 12
- Pages
- 4077-4082
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2146786154
- Cited by
- 304
- References
- 0
- FWCI
- 30.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.